| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.09 |